한글목차

세계의 이 치료 시장은 2025년 11억 4,000만 달러에서 2031년까지 15억 7,000만 달러에 이르고, CAGR 5.48%를 보일 것으로 예측됩니다.

주요 시장 성장 촉진요인

학령기 아동의 두부 이가증 확산이 이 치료 시장의 지속적인 성장의 주요 요인으로 작용하고 있습니다. 이 증상은 교육기관이나 보육시설에서 머리와 머리가 직접 접촉하는 방식으로 빠르게 확산되고 있으며, 효과적인 방역 솔루션에 대한 주기적인 수요가 발생하고 있습니다.

주요 시장 과제

피레스로이드 계열 약물에 대한 이가 생물학적 내성이 증가함에 따라 세계 이 치료 시장의 발전에 큰 장벽이 되고 있습니다. 일반적으로 '슈퍼 이'로 알려진 계통에서 관찰되는 이 생리적 적응증으로 인해 많은 표준 시판용 이약이 효과를 잃게 되었습니다.

주요 시장 동향

시장에서는 기존의 피레스로이드계 약물에 대한 광범위한 내성에 대응하기 위해 무독성 및 물리적 작용기전을 가진 제제로의 결정적인 전환이 이루어지고 있습니다. 소비자와 의료진은 신경독성 화학물질에 의존하지 않고 기계적 또는 새로운 생물학적 메커니즘을 통해 기생충을 퇴치하는 스피노사드, 디메티콘과 같은 성분을 함유한 제품을 점점 더 선호하고 있습니다.

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 이 치료 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 유형별(두피 이질, 체부 이질, 음부 이질)
  • 약제별(일반 의약품, 처방약)
  • 유통 채널별(병원 약국, 소매 약국, 온라인 약국)
  • 지역별
  • 기업별(2025)
• 시장 맵

제6장 북미의 이 치료 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 이 치료 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 이 치료 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 이 치료 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 남아프리카공화국

제10장 남미의 이 치료 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병(M&A)
• 제품 출시
• 최근 동향

제13장 세계의 이 치료 시장 : SWOT 분석

제14장 Porter의 Five Forces 분석

• 업계내 경쟁
• 신규 참여 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제15장 경쟁 구도

• Alliance Pharmaceuticals
• Omega Pharma
• Prestige Brands Holdings Inc.
• Johnson & Johnson
• Fleming Medical Ltd
• Oystershell Consumer Health, Inc
• Nisarg Pharma
• ParaPRO Pharmaceuticals
• ICB Pharma
• Marico

제16장 전략적 제안

제17장 회사 소개 및 면책조항

영문목차

The Global Lice Treatment Market will grow from USD 1.14 Billion in 2025 to USD 1.57 Billion by 2031 at a 5.48% CAGR. The Global Lice Treatment Market encompasses topical pediculicides, such as shampoos and lotions, alongside mechanical removal devices designed for the eradication of pediculosis infestations. The market's trajectory is fundamentally supported by the persistent prevalence of head lice among school-aged children and the expanding accessibility of over-the-counter therapeutic options.

Key Market Drivers

The escalating prevalence of pediculosis capitis among school-aged children serves as a primary catalyst for the sustained growth of the lice treatment market. This condition spreads rapidly in educational and childcare settings through direct head-to-head contact, creating a cyclical demand for effective eradication solutions. As classrooms and extracurricular activities facilitate transmission, the sheer volume of infestations necessitates frequent therapeutic interventions by parents and guardians.

Key Market Challenges

The escalating biological resistance of head lice to pyrethroid-based formulations constitutes a formidable barrier to the growth of the Global Lice Treatment Market. This physiological adaptation, observed in strains widely known as "super lice," renders many standard over-the-counter pediculicides ineffective. When these established chemical treatments fail to eradicate infestations, consumer confidence in conventional product lines diminishes significantly.

Key Market Trends

The market is witnessing a decisive transition toward non-toxic and physical mode-of-action formulations as a response to the widespread resistance of lice to traditional pyrethroid-based treatments. Consumers and healthcare providers are increasingly favoring products containing ingredients like spinosad or dimethicone, which utilize mechanical or novel biological mechanisms to eradicate infestations rather than relying on neurotoxic chemicals. This shift is driving significant revenue growth for pharmaceutical companies holding rights to these advanced therapies.

Key Market Players

• Alliance Pharmaceuticals
• Omega Pharma
• Prestige Brands Holdings Inc.
• Johnson & Johnson
• Fleming Medical Ltd
• Oystershell Consumer Health, Inc
• Nisarg Pharma
• ParaPRO Pharmaceuticals
• ICB Pharma
• Marico

Report Scope:

In this report, the Global Lice Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Lice Treatment Market, By Type:

• Pediculosis Capitis
• Pediculosis Corporis
• Pediculosis Pubis

Lice Treatment Market, By Drugs:

• OTC Drugs
• Prescription Drugs

Lice Treatment Market, By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Lice Treatment Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Lice Treatment Market.

Available Customizations:

Global Lice Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Lice Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Pediculosis Capitis, Pediculosis Corporis, Pediculosis Pubis)
  • 5.2.2. By Drugs (OTC Drugs, Prescription Drugs)
  • 5.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Lice Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Drugs
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Lice Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Drugs
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Lice Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Drugs
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Lice Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Drugs
      • 6.3.3.2.3. By Distribution Channel

7. Europe Lice Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Drugs
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Lice Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Drugs
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. France Lice Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Drugs
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. United Kingdom Lice Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Drugs
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Lice Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Drugs
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Lice Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Drugs
      • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Lice Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Drugs
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Lice Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Drugs
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Lice Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Drugs
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Lice Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Drugs
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Lice Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Drugs
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Lice Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Drugs
      • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Lice Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Drugs
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Lice Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Drugs
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. UAE Lice Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Drugs
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. South Africa Lice Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Drugs
      • 9.3.3.2.3. By Distribution Channel

10. South America Lice Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Drugs
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Lice Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Drugs
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Colombia Lice Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Drugs
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. Argentina Lice Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Drugs
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Lice Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Alliance Pharmaceuticals
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Omega Pharma
• 15.3. Prestige Brands Holdings Inc.
• 15.4. Johnson & Johnson
• 15.5. Fleming Medical Ltd
• 15.6. Oystershell Consumer Health, Inc
• 15.7. Nisarg Pharma
• 15.8. ParaPRO Pharmaceuticals
• 15.9. ICB Pharma
• 15.10. Marico

16. Strategic Recommendations

17. About Us & Disclaimer